Marshall Wace’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-619,913
| Closed | -$961K | – | 2537 |
|
|
2025
Q1 | $961K | Sell |
619,913
-137,622
| -18% | -$213K | ﹤0.01% | 1692 |
|
|
2024
Q4 | $1.78M | Hold |
757,535
| – | – | ﹤0.01% | 1384 |
|
|
2024
Q3 | $2.75M | Hold |
757,535
| – | – | ﹤0.01% | 1150 |
|
|
2024
Q2 | $2.64M | Sell |
757,535
-282,142
| -27% | -$982K | ﹤0.01% | 1132 |
|
|
2024
Q1 | $6.63M | Buy |
1,039,677
+542,724
| +109% | +$3.46M | 0.01% | 779 |
|
|
2023
Q4 | $3.2M | Buy |
+496,953
| New | +$3.2M | 0.01% | 885 |
|
|
2023
Q3 | – | Sell |
-25,496
| Closed | -$60.7K | – | 1839 |
|
|
2023
Q2 | $60.7K | Buy |
+25,496
| New | +$60.7K | ﹤0.01% | 1919 |
|
|
2022
Q1 | – | Sell |
-16,178
| Closed | -$85K | – | 2611 |
|
|
2021
Q4 | $85K | Buy |
+16,178
| New | +$85K | ﹤0.01% | 2723 |
|
|
2021
Q3 | – | Sell |
-297,749
| Closed | -$1.98M | – | 2388 |
|
|
2021
Q2 | $1.98M | Buy |
297,749
+198,736
| +201% | +$1.32M | 0.01% | 1135 |
|
|
2021
Q1 | $568K | Buy |
+99,013
| New | +$568K | ﹤0.01% | 1602 |
|
|
2020
Q3 | – | Sell |
-13,672
| Closed | -$220K | – | 1524 |
|
|
2020
Q2 | $220K | Sell |
13,672
-471,557
| -97% | -$7.59M | ﹤0.01% | 1363 |
|
|
2020
Q1 | $2.91M | Sell |
485,229
-194,952
| -29% | -$1.17M | 0.03% | 503 |
|
|
2019
Q4 | $8.98M | Buy |
680,181
+173,174
| +34% | +$2.29M | 0.06% | 306 |
|
|
2019
Q3 | $6.3M | Sell |
507,007
-8,398
| -2% | -$104K | 0.05% | 400 |
|
|
2019
Q2 | $8.3M | Buy |
515,405
+282,474
| +121% | +$4.55M | 0.07% | 325 |
|
|
2019
Q1 | $7.33M | Buy |
232,931
+112,489
| +93% | +$3.54M | 0.07% | 339 |
|
|
2018
Q4 | $3.96M | Buy |
+120,442
| New | +$3.96M | 0.04% | 517 |
|